Novogene Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,364.82 million compared to CNY 1,276 million a year ago. Revenue was CNY 1,364.82 million compared to CNY 1,276 million a year ago.

Net income was CNY 112.84 million compared to CNY 129.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.34 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.34 a year ago.